Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)

🩺 Protocol Summary

The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms

Primary Research Facility: Jacobs Institute (Buffalo, New York)

Review these 3 basic logistical and protocol criteria extracted from the public NIH record. (This is a preliminary logistical checklist, not an official clinical eligibility determination).

Diagnosed with, undergoing evaluation for, or seeking treatment related to Aneurysm?

🔍 Study Population / Focus Area (Source: Protocol Primary Condition)

Aged 22 Years or older?

🔍 Protocol Specified Minimum Age: 22 Years

Able to attend required clinic visits at Jacobs Institute (Buffalo, New York)?

🔍 Logistical Requirement: Site at Jacobs Institute

📍 Primary Site Map

Site: Jacobs Institute — Buffalo, New York

💰 Clinical Trial Costs & Insurance Coverage

Coverage for clinical trial participation varies depending on your health insurance policy, state legislation, and whether specific procedures are investigational research or routine medical care. Under federal law (Affordable Care Act § 2709), health insurers generally cannot drop coverage or refuse to pay for routine patient care costs incurred in approved clinical trials.

💡 Always ask the study coordinator for the trial's official Informed Consent Form, which outlines all sponsor-funded research items versus procedures billed to your insurance.